Hsbc Holdings PLC Makes New $1.04 Million Investment in Acadia Healthcare Company, Inc. $ACHC

Hsbc Holdings PLC purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 35,563 shares of the company’s stock, valued at approximately $1,045,000.

A number of other hedge funds have also modified their holdings of ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Acadia Healthcare in the 1st quarter worth $1,600,000. Goldman Sachs Group Inc. increased its stake in Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after buying an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Acadia Healthcare by 8.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after acquiring an additional 27,207 shares during the period. American Century Companies Inc. lifted its position in shares of Acadia Healthcare by 531.5% in the second quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock valued at $2,399,000 after acquiring an additional 88,995 shares in the last quarter. Finally, Prudential Financial Inc. boosted its stake in shares of Acadia Healthcare by 21.9% in the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after acquiring an additional 1,780 shares during the period.

Acadia Healthcare Stock Down 3.5%

Shares of NASDAQ ACHC opened at $27.56 on Tuesday. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The firm has a 50-day simple moving average of $30.51 and a two-hundred day simple moving average of $26.25. The company has a market cap of $2.57 billion, a P/E ratio of -2.21, a PEG ratio of 9.20 and a beta of 0.64. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. During the same quarter in the prior year, the firm posted $0.83 earnings per share. The company’s quarterly revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.

Analyst Ratings Changes

ACHC has been the topic of several recent analyst reports. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Acadia Healthcare in a research note on Wednesday, July 29th. TD Cowen lifted their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. UBS Group boosted their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $29.85.

Read Our Latest Stock Report on Acadia Healthcare

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Featured Stories

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.